trim28 kap1 Search Results


94
NSJ Bioreagents trim28 antibody / kap1
Trim28 Antibody / Kap1, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trim28 antibody / kap1/product/NSJ Bioreagents
Average 94 stars, based on 1 article reviews
trim28 antibody / kap1 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

95
Proteintech proteintech 66630 1 ig p chk2
Proteintech 66630 1 Ig P Chk2, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteintech 66630 1 ig p chk2/product/Proteintech
Average 95 stars, based on 1 article reviews
proteintech 66630 1 ig p chk2 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

90
ProSci Incorporated rabbit α trim28
Rabbit α Trim28, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit α trim28/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
rabbit α trim28 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

88
Proteintech antibody targeting trim28
Figure 1. <t>TRIM28</t> expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.
Antibody Targeting Trim28, supplied by Proteintech, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody targeting trim28/product/Proteintech
Average 88 stars, based on 1 article reviews
antibody targeting trim28 - by Bioz Stars, 2026-06
88/100 stars
  Buy from Supplier

90
OriGene tif1β cdna clones
Figure 1. <t>TRIM28</t> expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.
Tif1β Cdna Clones, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tif1β cdna clones/product/OriGene
Average 90 stars, based on 1 article reviews
tif1β cdna clones - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
OriGene kap1 sirna
Figure 1. <t>TRIM28</t> expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.
Kap1 Sirna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kap1 sirna/product/OriGene
Average 90 stars, based on 1 article reviews
kap1 sirna - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
OriGene kap1 (trim28) human shrna plasmid kit
Figure 1. <t>TRIM28</t> expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.
Kap1 (Trim28) Human Shrna Plasmid Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kap1 (trim28) human shrna plasmid kit/product/OriGene
Average 90 stars, based on 1 article reviews
kap1 (trim28) human shrna plasmid kit - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

N/A
TRIM28 phospho Ser824 rabbit polyclonal antibody
  Buy from Supplier


N/A
TRIM28 mouse monoclonal antibody clone OTI5E10 Biotinylated
  Buy from Supplier


Image Search Results


Figure 1. TRIM28 expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.

Journal: Oncology reports

Article Title: TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.

doi: 10.3892/or.2018.6235

Figure Lengend Snippet: Figure 1. TRIM28 expression is elevated in cervical cancer tissues and cell lines. (A) Analysis from the Oncomine database showing that TRIM28 mRNA expression is significantly elevated in cervical cancer tissues (n=40) compared with that in normal tissues (n=5). The data were obtained from a previous study (35). (B) TRIM28 mRNA levels in 20 paired cervical cancer samples and adjacent normal tissues examined by qRT‑PCR. (C) Immunohistochemical staining of normal and cervical cancer tissues with anti-TRIM28 antibody. The expression levels of TRIM28 in human cervical cancer cells and normal human cervical tissues were measured by qRT‑PCR (D) and western blotting (E). Data are presented as means ± SD. *P<0.05.

Article Snippet: After blocking the endogenous peroxidase with 3% hydrogen peroxide, the sections were washed with Tris-buffered saline (TBS) and then incubated with a primary antibody targeting TRIM28 (Proteintech, Hubei, China) for 1 h at 37 ̊C.

Techniques: Expressing, Immunohistochemical staining, Staining, Western Blot

Figure 3. TRIM28 enhances cervical cancer cell tumorigenicity. (A) Tumor volumes were measured on the indicated days. (B) At the end of the experiment, the weights were measured. (C) The proliferation index (right) was determined based on the percentage of Ki67-positive cells (left). (D) Western blot analysis of TRIM28 and p-mTOR protein expression in indicated tumor xenografts. Data are presented as means ± SD. *P<0.05.

Journal: Oncology reports

Article Title: TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.

doi: 10.3892/or.2018.6235

Figure Lengend Snippet: Figure 3. TRIM28 enhances cervical cancer cell tumorigenicity. (A) Tumor volumes were measured on the indicated days. (B) At the end of the experiment, the weights were measured. (C) The proliferation index (right) was determined based on the percentage of Ki67-positive cells (left). (D) Western blot analysis of TRIM28 and p-mTOR protein expression in indicated tumor xenografts. Data are presented as means ± SD. *P<0.05.

Article Snippet: After blocking the endogenous peroxidase with 3% hydrogen peroxide, the sections were washed with Tris-buffered saline (TBS) and then incubated with a primary antibody targeting TRIM28 (Proteintech, Hubei, China) for 1 h at 37 ̊C.

Techniques: Western Blot, Expressing

Figure 2. TRIM28 promotes cervical cancer cell proliferation by accelerating the cell cycle. (A) Western blot analysis of TRIM28 protein expression in TRIM28-infected cells and TRIM28 shRNA-infected cells. GAPDH was used as the loading control. (B) Effects of TRIM28 upregulation or downregulation on the proliferation of SiHa or CaSki cells analyzed by the MTT assay. (C) Representative micrographs (left) and quantification (right) of colonies formed by the indicated cervical cancer cell lines. (D) Cell cycle progression of the indicated cervical cancer cell lines analyzed by flow cytometry. (E) Representative images (left) and quantification (right) of BrdU-positive cells in the indicated cervical cancer cell lines. Data are presented as means ± SD. *P<0.05.

Journal: Oncology reports

Article Title: TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.

doi: 10.3892/or.2018.6235

Figure Lengend Snippet: Figure 2. TRIM28 promotes cervical cancer cell proliferation by accelerating the cell cycle. (A) Western blot analysis of TRIM28 protein expression in TRIM28-infected cells and TRIM28 shRNA-infected cells. GAPDH was used as the loading control. (B) Effects of TRIM28 upregulation or downregulation on the proliferation of SiHa or CaSki cells analyzed by the MTT assay. (C) Representative micrographs (left) and quantification (right) of colonies formed by the indicated cervical cancer cell lines. (D) Cell cycle progression of the indicated cervical cancer cell lines analyzed by flow cytometry. (E) Representative images (left) and quantification (right) of BrdU-positive cells in the indicated cervical cancer cell lines. Data are presented as means ± SD. *P<0.05.

Article Snippet: After blocking the endogenous peroxidase with 3% hydrogen peroxide, the sections were washed with Tris-buffered saline (TBS) and then incubated with a primary antibody targeting TRIM28 (Proteintech, Hubei, China) for 1 h at 37 ̊C.

Techniques: Western Blot, Expressing, Infection, shRNA, Control, MTT Assay, Flow Cytometry

Figure 4. TRIM28 promotes cervical cancer cell proliferation via the mTOR signaling pathway. (A) Western blot analysis of TRIM28, p-mTOR(S2448), mTOR, p-S6K1(T389), and S6K1 in TRIM28 shRNA-infected CaSki cells and TRIM28-infected SiHa cells in the presence or absence of 20 nM evero- limus (EVE) for 48 h. GAPDH served as the loading control. (B-D) Cell proliferation, cell cycle, and BrdU incorporation were analyzed in TRIM28-infected SiHa cells in the presence or absence of EVE for 48 h. Data are presented as means ± SD. *P<0.05.

Journal: Oncology reports

Article Title: TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.

doi: 10.3892/or.2018.6235

Figure Lengend Snippet: Figure 4. TRIM28 promotes cervical cancer cell proliferation via the mTOR signaling pathway. (A) Western blot analysis of TRIM28, p-mTOR(S2448), mTOR, p-S6K1(T389), and S6K1 in TRIM28 shRNA-infected CaSki cells and TRIM28-infected SiHa cells in the presence or absence of 20 nM evero- limus (EVE) for 48 h. GAPDH served as the loading control. (B-D) Cell proliferation, cell cycle, and BrdU incorporation were analyzed in TRIM28-infected SiHa cells in the presence or absence of EVE for 48 h. Data are presented as means ± SD. *P<0.05.

Article Snippet: After blocking the endogenous peroxidase with 3% hydrogen peroxide, the sections were washed with Tris-buffered saline (TBS) and then incubated with a primary antibody targeting TRIM28 (Proteintech, Hubei, China) for 1 h at 37 ̊C.

Techniques: Western Blot, shRNA, Infection, Control, BrdU Incorporation Assay